A Study to Evaluate Safety and Anti-Tumor Activity of RO7284755 Alone or in Combination with Atezolizumab in Participants with Advanced and/or Metastatic Solid Tumors

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503749-76-00

Acronym

BP41628

Enrollment

162

Registered

2023-12-19

Start date

2020-03-06

Completion date

2025-10-02

Last updated

2025-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Denmark, Netherlands, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026